Genmab A/S
CSE:GMAB

Watchlist Manager

Genmab A/S

CSE:GMAB

Watchlist

Dividends

Price: 1 485 DKK 1.57% Market Closed

Market Cap: 98.3B DKK

Have any thoughts about
Genmab A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 1485 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GMAB Alert

Genmab A/S

1485

+23 (+1.57%)

52 Week Range	1 427.5 2 214
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genmab A/S

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genmab A/S.

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Summarize the latest earnings call
of Genmab A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genmab A/S.

Provide P/S
for Genmab A/S.

Provide P/E
for Genmab A/S.

Provide P/OCF
for Genmab A/S.

Provide P/FCFE
for Genmab A/S.

Provide P/B
for Genmab A/S.

Provide EV/S
for Genmab A/S.

Provide EV/GP
for Genmab A/S.

Provide EV/EBITDA
for Genmab A/S.

Provide EV/EBIT
for Genmab A/S.

Provide EV/OCF
for Genmab A/S.

Provide EV/FCFF
for Genmab A/S.

Provide EV/IC
for Genmab A/S.

Show me price targets
for Genmab A/S made by professional analysts.

What are the Revenue projections
for Genmab A/S?

How accurate were the past Revenue estimates
for Genmab A/S?

What are the Net Income projections
for Genmab A/S?

How accurate were the past Net Income estimates
for Genmab A/S?

What are the EPS projections
for Genmab A/S?

How accurate were the past EPS estimates
for Genmab A/S?

What are the EBIT projections
for Genmab A/S?

How accurate were the past EBIT estimates
for Genmab A/S?

Compare the revenue forecasts
for Genmab A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genmab A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genmab A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genmab A/S compared to its peers.

Compare the P/E ratios
of Genmab A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Genmab A/S with its peers.

Analyze the financial leverage
of Genmab A/S compared to its main competitors.

Show all profitability ratios
for Genmab A/S.

Provide ROE
for Genmab A/S.

Provide ROA
for Genmab A/S.

Provide ROIC
for Genmab A/S.

Provide ROCE
for Genmab A/S.

Provide Gross Margin
for Genmab A/S.

Provide Operating Margin
for Genmab A/S.

Provide Net Margin
for Genmab A/S.

Provide FCF Margin
for Genmab A/S.

Show all solvency ratios
for Genmab A/S.

Provide D/E Ratio
for Genmab A/S.

Provide D/A Ratio
for Genmab A/S.

Provide Interest Coverage Ratio
for Genmab A/S.

Provide Altman Z-Score Ratio
for Genmab A/S.

Provide Quick Ratio
for Genmab A/S.

Provide Current Ratio
for Genmab A/S.

Provide Cash Ratio
for Genmab A/S.

What is the historical Revenue growth
over the last 5 years for Genmab A/S?

What is the historical Net Income growth
over the last 5 years for Genmab A/S?

What is the current Free Cash Flow
of Genmab A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genmab A/S.

P/E
Price to Earnings

17.1

Current

33.5

Median

22.1

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

17.1

Market Cap

94.2B DKK

Net Income

5.5B DKK

All Countries

Forward Multiples

			Market Cap	P/E
DK		Genmab A/S CSE:GMAB	94.2B DKK	17.1
FR		Pharnext SCA OTC:PNEXF	6T USD	-180 740.1
US		Abbvie Inc NYSE:ABBV	315.2B USD	62
US		Amgen Inc NASDAQ:AMGN	141.9B USD	33.5
US		Gilead Sciences Inc NASDAQ:GILD	116.4B USD	923.6
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	104.5B USD	-217.7
US	E	Epizyme Inc F:EPE	94.1B EUR	-472.7
AU		CSL Ltd ASX:CSL	135.7B AUD	32.1
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.7B USD	16.9
US	S	Seagen Inc F:SGT	39.3B EUR	-54.7
NL		argenx SE XBRU:ARGX	36B EUR	-135.6

				Earnings Growth	P/E to Growth
DK		Genmab A/S CSE:GMAB	Average P/E: 180.9 17.1	89%	0.2
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -180 740.1	N/A	N/A
US		Abbvie Inc NYSE:ABBV	62	413%	0.2
US		Amgen Inc NASDAQ:AMGN	33.5	73%	0.5
US		Gilead Sciences Inc NASDAQ:GILD	923.6	77%	12
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -217.7	48%	N/A
US	E	Epizyme Inc F:EPE	Negative Multiple: -472.7	N/A	N/A
AU		CSL Ltd ASX:CSL	32.1	65%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.9	44%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -54.7	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -135.6	N/A	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

16.5

2-Years Forward

P/E

14.4

3-Years Forward

P/E

11.4

	Franklin Covey Co NYSE:FC	36.42 USD 0.03%
	Mohawk Industries Inc NYSE:MHK	119.54 USD 0.32%
	Ardmore Shipping Corp NYSE:ASC	11.88 USD 5.04%
	ASGN Inc NYSE:ASGN	83.37 USD -0.6%
	Skyworks Solutions Inc NASDAQ:SWKS	90.19 USD 1.62%
	Weatherford International PLC NASDAQ:WFRD	67.715 USD 0.92%

	Johnson & Johnson NYSE:JNJ	145.27 USD 0.55%
	Bank of America Corp NYSE:BAC	43.89 USD -0.63%
	Mastercard Inc NYSE:MA	528.96 USD 0.18%
	Salesforce Inc NYSE:CRM	342.9 USD -0.22%
	Abbvie Inc NYSE:ABBV	178.39 USD 1.6%
	Home Depot Inc NYSE:HD	392.45 USD -0.04%

	Arista Networks Inc NYSE:ANET	113.09 USD 0.25%
	Visa Inc NYSE:V	317.22 USD -0.15%
	Texas Pacific Land Corp NYSE:TPL	1 139.45 USD 0.56%
	KLA Corp NASDAQ:KLAC	647.99 USD 2.96%
	Manhattan Associates Inc NASDAQ:MANH	278.82 USD -0.51%
	Pinduoduo Inc NASDAQ:PDD	100.58 USD 1.08%

	Salesforce Inc NYSE:CRM	342.9 USD -0.22%
	Accenture PLC NYSE:ACN	358.77 USD -2.07%
	ServiceNow Inc NYSE:NOW	1 088.26 USD -0.27%
	EOG Resources Inc NYSE:EOG	119.85 USD 0.68%
	Copart Inc NASDAQ:CPRT	58.36 USD 0.24%
	Applied Materials Inc NASDAQ:AMAT	167.46 USD 2.37%

Genmab A/S
CSE:GMAB

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genmab A/S CSE:GMAB

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Genmab A/S
CSE:GMAB

P/E
Price to Earnings